Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$8.8 - $16.2 $6,089 - $11,210
-692 Reduced 2.54%
26,580 $6,000
Q1 2022

May 09, 2022

SELL
$12.5 - $52.0 $486,037 - $2.02 Million
-38,883 Reduced 58.78%
27,272 $9,000
Q4 2021

Feb 11, 2022

SELL
$46.5 - $104.0 $1.31 Million - $2.94 Million
-28,240 Reduced 29.92%
66,155 $62,000
Q3 2021

Nov 12, 2021

BUY
$80.5 - $175.0 $7.6 Million - $16.5 Million
94,395 New
94,395 $195,000

About Enveric Biosciences, Inc.


  • Ticker ENVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,078,270
  • Market Cap $1.04M
  • Description
  • Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...
More about ENVB
Track This Portfolio

Track Scotia Capital Inc. Portfolio

Follow Scotia Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.